Fulcrum Therapeutics, Inc. (FULC)
Nasdaq: FULC · Pharmaceutical Preparations · Cambridge, MA · filing with the SEC since 2016
Who runs Fulcrum Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Gould Robert J
Interim President & CEO. First filing Jul 2019, latest Jul 2, 2026, 21 filings in all.
Officers reporting now
5
of 13 people with a filing in the last fifteen months
Directors reporting now
8
26 people on the record since 2019
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Gould Robert J | Interim President & CEO | Jul 2019 | Jul 2, 2026 | 4 · $700,000 |
| Sapir Alex | President & Chief Executive Officer | Jul 2023 | Feb 4, 2026 | none |
| Musso Alan A | Chief Financial Officer | Aug 2023 | Feb 4, 2026 | none |
| Oltmans Curtis Gale | Chief Legal Officer | Dec 2020 | Feb 4, 2026 | 1 · $0.00 |
| Tourangeau Greg | Principal Accounting Officer | Mar 2022 | Feb 4, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Banks Sonja | director | Dec 2021 | Jul 2, 2026 | none |
| Dorton Katina | director | Jan 2020 | Jul 2, 2026 | none |
| Ezekowitz Alan | director | Jul 2019 | Jul 2, 2026 | 1 · $100,000 |
| Geraghty James A | director | Jul 2019 | Jul 2, 2026 | none |
| Haviland Kate | director | Jul 2019 | Jul 2, 2026 | none |
| Hill Colin | director | Jun 2024 | Jul 2, 2026 | none |
| King Rachel K. | director | Nov 2024 | Jul 2, 2026 | none |
| Lehrer-Graiwer Joshua | director | May 2026 | May 1, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Tang Capital Management LLC | 10% owner | Jul 2026 | Jul 20, 2026 | none |
| Tang Kevin | 10% owner | Jul 2026 | Jul 20, 2026 | none |
| Kolchinsky Peter | 10% owner | Aug 2022 | Dec 10, 2025 | none |
| Ra Capital Healthcare Fund LP | 10% owner | Aug 2022 | Dec 10, 2025 | 3 · $58.4M |
| Ra Capital Management, L.P. | 10% owner | Aug 2022 | Dec 10, 2025 | none |
| Shah Rajeev M. | 10% owner | Aug 2022 | Dec 10, 2025 | none |
Earlier names on the record27, newest filing first
Collins James J. · director · last filing Jun 2024Horn Patrick Taylor · officer · last filing Mar 2024Hayes Melvin H. III · officer · last filing Apr 2023Rajavelu Esther · officer · last filing Feb 2023Tepper Robert I · 10% owner · last filing Dec 2022Third Rock Ventures Gp III, L.P. · 10% owner · last filing Dec 2022Third Rock Ventures III, L.P. · 10% owner · last filing Dec 2022Trv Gp III, LLC · 10% owner · last filing Dec 2022Arroyo Santiago · officer · last filing Nov 2022Stuart Bryan · officer · last filing Jan 2022Dunn Judith · officer · last filing Jan 2022Morabito Christopher · officer · last filing Jan 2022Thomson Peter G. · officer · last filing Jan 2022Levin Mark J · director · last filing Nov 2021Starr Kevin P · 10% owner · last filing Nov 2021Moxham Christopher · officer · last filing Aug 2021Wallace Owen B. · officer · last filing Sep 2020Cadavid Diego · officer · last filing Jul 2020Glaxosmithkline PLC · 10% owner · last filing Jul 2019Sanofi · 10% owner · last filing Jul 20196 Dimensions Capital, L.P. · 10% owner · last filing Jul 2019Casdin Capital, LLC · 10% owner · last filing Jul 2019Casdin Eli · 10% owner · last filing Jul 2019Casdin Partners Gp, LLC · 10% owner · last filing Jul 2019Casdin Partners Master Fund, L.P. · 10% owner · last filing Jul 2019Maris William J · 10% owner · last filing Jul 2019Section 32 Fund 2, LP · 10% owner · last filing Jul 2019
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.